Skip navigation
Skip navigation

Bisphosphonate guidelines for treatment and prevention of myeloma bone disease

Lee, Oi Lin; Horvath, N.; Lee, Cindy; Joshua, D.; Ho, J.; Szer, Jeff; Quach, H.; Spencer, Andrew; Mollee, P.; Roberts, Andrew A.; Talaulikar, Dipti; Johnston, Anna M.


Multiple myeloma (MM) is a haematological malignancy characterised by the clonal proliferation of plasma cells in the bone marrow. More than 80% of patients with MM display evidence of myeloma bone disease (MBD), characterised by the formation of osteolytic lesions throughout the axial and appendicular skeleton. MBD significantly increases the risk of skeletal-related events such as pathologic fracture, spinal cord compression and hypercalcaemia. MBD is the result of MM plasma cells-mediated...[Show more]

CollectionsANU Research Publications
Date published: 2017
Type: Journal article
Source: Internal Medicine Journal
DOI: 10.1111/imj.13502
Access Rights: Free Access via Publisher Site


File Description SizeFormat Image
Internal Medicine Journal - 2017 - Lee - Bisphosphonate guidelines for treatment and prevention of myeloma bone disease.pdf528.21 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator